FDA 503B outsourcing facilities in Colorado
Colorado has 4 FDA-registered 503B outsourcing facilities in the PeptideGrids directory, 4 with FDA drug recalls on record, the earliest registered in 2017. 503B facilities compound sterile medications in bulk under FDA cGMP standards and are a primary supply route for compounded peptides and GLP-1s during drug shortages.
| Facility | City | FDA-registered since | FDA recalls |
|---|---|---|---|
| Denver Solutions, LLC, dba Leiters Health | Englewood | 2017 | 22 |
| STAQ Pharma, Inc. | Denver | 2019 | 6 |
| BSO LLC | Golden | 2024 | 5 |
| BSO LLC | Lakewood | 2024 | 5 |
503B compounding in Colorado
A 503B outsourcing facility registers with the FDA under the Drug Quality and Security Act and is inspected against cGMP manufacturing standards. In addition to that federal registration, a facility shipping into or operating in Colorado must hold the appropriate state pharmacy license. Verify any facility's current license with the Colorado State Board of Pharmacy.
Compounded peptides and GLP-1s
503B facilities are a primary supply route for compounded peptides and GLP-1s, including Semaglutide, Tirzepatide, BPC-157, Retatrutide. Browse the full GLP-1 and therapeutic peptide databases, or the national directory.
Frequently asked questions
How many FDA 503B outsourcing facilities are in Colorado?
4 FDA-registered 503B outsourcing facilities are listed in Colorado on PeptideGrids, the earliest registered in 2017.
Which Colorado 503B facilities have FDA recalls on record?
4 of the 4 Colorado facilities have FDA drug recalls on record; the table above shows the count per facility.
How do I verify a pharmacy license in Colorado?
Use the Colorado State Board of Pharmacy license lookup to confirm a facility's current license status.
Facilities sourced from the FDA registered outsourcing facilities list. Recall counts from the FDA openFDA drug enforcement database.